Faculty, Staff and Student Publications
Publication Date
10-25-2022
Journal
ACS Nano
Abstract
The continuing emergence of variants of the SARS-CoV-2 virus requires the development of modular molecular therapies. Here, we engineered a recombinant amphiphilic protein, oleosin, to spontaneously self-assemble into multivalent micellar nanostructures which can block the Spike S1 protein of SARS-CoV-2 pseudoviruses (PVs). Short recombinant proteins like oleosin can be formulated more easily than antibodies and can be functionalized with precision through genetic engineering. We cloned S1-binding mini-protein genes called LCB
Keywords
Humans, Micelles, SARS-CoV-2, Escherichia coli, COVID-19, Recombinant Proteins, Peptides